Free Trial

Novo Integrated Sciences (NVOS) Competitors

$0.04 +0.01 (+23.08%)
(As of 12/20/2024 04:19 PM ET)

NVOS vs. CYD, SMX, HLP, MOG-A, STRCW, ASML, CARR, JCI, BKR, and SYM

Should you be buying Novo Integrated Sciences stock or one of its competitors? The main competitors of Novo Integrated Sciences include China Yuchai International (CYD), SMX (Security Matters) Public (SMX), Hongli Group (HLP), Moog (MOG-A), Palladyne AI (STRCW), ASML (ASML), Carrier Global (CARR), Johnson Controls International (JCI), Baker Hughes (BKR), and Symbotic (SYM). These companies are all part of the "machinery" industry.

Novo Integrated Sciences vs.

Novo Integrated Sciences (NASDAQ:NVOS) and China Yuchai International (NYSE:CYD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment.

China Yuchai International received 190 more outperform votes than Novo Integrated Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
Novo Integrated SciencesN/AN/A
China Yuchai InternationalOutperform Votes
190
57.40%
Underperform Votes
141
42.60%

China Yuchai International has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.06-$13.22MN/AN/A
China Yuchai International$19.18B0.00$40.19M$1.296.81

Novo Integrated Sciences has a beta of -1.9, indicating that its stock price is 290% less volatile than the S&P 500. Comparatively, China Yuchai International has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

China Yuchai International has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -179.95%. China Yuchai International's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-179.95% -122.84% -68.11%
China Yuchai International N/A N/A N/A

5.7% of Novo Integrated Sciences shares are held by institutional investors. 10.4% of Novo Integrated Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Novo Integrated Sciences had 1 more articles in the media than China Yuchai International. MarketBeat recorded 1 mentions for Novo Integrated Sciences and 0 mentions for China Yuchai International. Novo Integrated Sciences' average media sentiment score of 0.00 equaled China Yuchai International'saverage media sentiment score.

Company Overall Sentiment
Novo Integrated Sciences Neutral
China Yuchai International Neutral

Summary

China Yuchai International beats Novo Integrated Sciences on 7 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVOS vs. The Competition

MetricNovo Integrated SciencesEngines & turbines IndustryMedical SectorNASDAQ Exchange
Market Cap$789,000.00$5.44B$5.14B$9.08B
Dividend YieldN/A2.72%5.09%4.23%
P/E RatioN/A10.4690.0517.18
Price / Sales0.061.371,117.14116.99
Price / CashN/A11.6443.0437.86
Price / Book0.022.574.784.78
Net Income-$13.22M$111.80M$120.31M$225.60M
7 Day PerformanceN/A5.20%-1.92%-1.23%
1 Month PerformanceN/A6.46%11.51%3.36%
1 Year PerformanceN/A99.12%30.61%16.60%

Novo Integrated Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVOS
Novo Integrated Sciences
N/A$0.04
+23.1%
N/A-96.5%$789,000.00$13.52M0.00127
CYD
China Yuchai International
N/A$9.02
-3.1%
N/A+3.8%$2.44M$19.18B7.218,177Gap Up
SMX
SMX (Security Matters) Public
0.1138 of 5 stars
$0.31
+7.9%
N/A-99.7%$900,000.00N/A0.00N/AGap Down
HLP
Hongli Group
N/A$1.31
-4.4%
N/A+30.1%$0.00$14.05M0.00207
MOG-A
Moog
N/A$202.73
-1.2%
N/A+32.6%$0.00N/A24.4814,000High Trading Volume
STRCW
Palladyne AI
N/A$0.19
+12.1%
N/A+2,828.8%$0.00N/A0.0070
ASML
ASML
4.5042 of 5 stars
$723.24
+0.6%
$943.83
+30.5%
-3.3%$284.54B$26.24B37.9242,416
CARR
Carrier Global
4.7929 of 5 stars
$71.73
-1.8%
$83.50
+16.4%
+22.3%$64.36B$24.80B18.4853,000
JCI
Johnson Controls International
4.7835 of 5 stars
$84.05
+1.7%
$80.38
-4.4%
+47.4%$55.66B$22.95B32.5394,000Analyst Upgrade
Positive News
BKR
Baker Hughes
4.3091 of 5 stars
$41.89
-0.6%
$45.12
+7.7%
+18.5%$41.45B$25.51B18.8158,000Analyst Forecast
SYM
Symbotic
3.651 of 5 stars
$27.07
+0.7%
$42.54
+57.1%
-53.1%$15.90B$1.82B-452.501,650

Related Companies and Tools


This page (NASDAQ:NVOS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners